Anke Pierik

Anke Pierik is currently working as the Chief Technology Officer and Chief Operating Officer at InnoSIGN, specializing in mRNA-based OncoSIGNal pathway activity profiling technology for precision medicine. Prior to this role, Anke worked as a Quality Manager at Philips within the MPDx venture, where Anke was responsible for quality management and project management. Anke also has a background in research and development projects at Philips Research as a Senior Scientist and project leader, focusing on molecular pathology/diagnostics. With a PhD in Chemical Engineering from Eindhoven University of Technology, Anke has extensive experience in technology development, project management, and stakeholder management.